TLSA · Tiziana Life Sciences Ltd
Market Cap
$128.53M
Shares
127.26M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.99
Open$1.02
Day$0.97–1.05
52W close$0.89–2.29
Avg vol 30d893K
Short int1.7M · 1.3% float · 1.3d
Short vol20%
DataJul 2020–Aug 2026
Raw chart and full-history price indicators begin at the captured split on Jul 31, 2020; bars on opposite sides are not compared.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment adviceOverall
Strong Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 14.9 · calm
Equity put/call 0.70
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−27%
below
Price vs 50-day avg
−10%
below
RSI (14)
41
neutral
MACD trend
Negative
52-week position
7%
near low
Momentum
relative strength
1-month return
+2%
trailing
6-month return
−28%
trailing
YTD return
−34%
this year
Relative strength
−41%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow
Distributing
-3% holders QoQ · +6 funds added
Insider flow
Accumulating
Net +$1.0M over 90 days · 0% sells
Short interest
Falling
1.34% of float · ▼ -0.2% MoM · 1.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
32 holders — mid 3-yr range
Squeeze score
35
low risk · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
76%
annualized · 1-yr
Max drawdown
−61%
past year
ATR
10.3%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−27%
Bearish
Price vs 50-day avg
−10%
Bearish
RSI (14)
41
Neutral
MACD trend
Negative
Bearish
52-week position
7%
Bearish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow
Distributing
-3% holders QoQ · +6 funds added
Insider flow
Accumulating
Net +$1.0M over 90 days · 0% sells
Short interest
Falling
1.34% of float · ▼ -0.2% MoM · 1.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
32 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $1
Now $1 · 7%
Range high $2
vs 200-day avg -27%
vs 50-day avg -10%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
TLSA
this stock
Tiziana Life Sciences Ltd
|
$128.53M | -33.7% | — | — | 1.3% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$137.30B | +20.1% | +46.2% | 31.6 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$81.77B | +3.5% | +20.8% | 19.7 | 2.3% |
|
ARGX
Argenx SE
|
$64.16B | +22.7% | — | — | 1.9% |
|
CSLLY
Csl Ltd
|
$59.23B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Reducing
Holders
32
- % held
- 1.9%
- Net QoQ
- -694.1K sh
- Top holder
- Dauntless Investment Grou…
Held
Float
Short & Settlement
Smart Money
Filings
Earnings & Events
Performance
Raw-price comparisons begin at the captured split on Jul 31, 2020; windows that need an earlier baseline remain unavailable.
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| TLSA | -14.1% | +1.9% | -27.9% | -4.1% | -33.7% |
| SPY | +0.5% | +1.2% | +13.3% | +2.7% | +12.5% |
| vs SPY | -14.6% | +0.7% | -41.2% | -6.8% | -46.2% |
Key facts
CIK
1723069
CUSIP
G88912103
13F (30d)
22 filings
22 filers
Visit website
Investor relations